Progesterone’s relationship with cortisol is far more tangled than the clean “progesterone lowers cortisol” claim that circulates in wellness spaces. Some evidence suggests progesterone can blunt cortisol spikes during acute stress, and baseline cortisol does trend slightly lower during the high-progesterone phase of the menstrual cycle. But other evidence shows the opposite in specific contexts, and at least one rigorous trial in men found no cortisol-lowering effect at all from high-dose progesterone. The honest answer depends heavily on the pathway you’re asking about, whether you mean baseline cortisol or the stress response, and whether progesterone itself or one of its metabolites is doing the work.
What the Menstrual Cycle Tells Us
The menstrual cycle is the most natural experiment we have for this question. During the follicular phase (roughly the first half of the cycle), progesterone is low. During the luteal phase (the second half), progesterone rises dramatically. If progesterone meaningfully suppresses cortisol, you’d expect cortisol to drop when progesterone peaks.
A meta-analysis pooling data across multiple studies found that resting cortisol is indeed slightly higher in the follicular phase than in the luteal phase, though the effect is small.1PubMed Central. Higher Circulating Cortisol in the Follicular vs. Luteal Phase of the Menstrual Cycle: A Meta-Analysis A separate study measuring cortisol responses to exercise similarly found higher resting cortisol in the follicular phase.2PubMed Central. Effects of the Menstrual Cycle Phase on Cortisol Responses to Maximum Exercise in Women With and Without Premenstrual Syndrome On the surface, this supports the idea that elevated progesterone coincides with lower cortisol. But coincidence and causation are different animals. Estrogen, luteinizing hormone, and other cycling hormones are also shifting across the menstrual cycle, so attributing the cortisol difference specifically to progesterone is a leap the data doesn’t fully support.
The stress-response picture muddies things further. When researchers exposed women to a laboratory mental-stress task, those in the luteal phase actually showed higher post-stress cortisol than women in the follicular phase.3PubMed. The relationship between the menstrual cycle and cortisol secretion: Daily and stress-invoked cortisol patterns So while resting cortisol may run a touch lower when progesterone is high, the cortisol system may be more reactive to stress during the same window. That’s a genuinely contradictory pattern that doesn’t map onto a simple “progesterone suppresses cortisol” narrative.
What Happens When You Give Progesterone to People
The menstrual cycle is messy because so many hormones move at once. Direct administration studies give a cleaner look at what progesterone alone does to cortisol. Here, results split sharply.
In a placebo-controlled trial, healthy men received a 50 mg dose of progesterone before undergoing a standardized psychosocial stress test. Progesterone significantly reduced the peak cortisol spike compared to placebo.4PubMed Central. Effects of acute progesterone administration upon responses to acute psychosocial stress in men That’s a meaningful result and probably the single strongest piece of evidence in favor of the “progesterone lowers cortisol” idea, at least in the context of acute stress.
But a different study used a much higher dose of progesterone, infused directly into healthy men to reach concentrations comparable to late pregnancy, and found no effect whatsoever on cortisol. Baseline cortisol didn’t change. Cortisol responses to a hormone stimulation test didn’t change. Even unbound (free) cortisol in saliva was unaffected, suggesting progesterone wasn’t even competing for binding sites on cortisol’s transport protein in blood.5European Journal of Endocrinology. High-dose progesterone infusion in healthy males: evidence against antiglucocorticoid activity of progesterone The researchers explicitly concluded that progesterone showed no antiglucocorticoid activity, and they went further, questioning whether the hormonal changes seen in pregnancy are really driven by progesterone blocking cortisol at all.
How do you reconcile a 50 mg oral dose blunting stress cortisol and a high-dose infusion doing nothing to baseline cortisol? The most likely explanation is that the pathways matter enormously. Oral progesterone gets metabolized by the liver into compounds like allopregnanolone, a neurosteroid that acts on the brain’s calming circuits. An infusion that bypasses the liver may produce far less of these metabolites. In other words, it may not be progesterone itself that blunts the cortisol stress response, but what your body turns progesterone into.
Allopregnanolone and the Brain’s Stress Brake
When progesterone is taken orally or produced naturally, a portion of it gets converted into allopregnanolone, sometimes called “allo” in research shorthand. Allopregnanolone is a potent enhancer of GABA, the brain’s main inhibitory signaling system. It also participates in the negative feedback loop that dials down the stress-hormone axis after activation.6PubMed Central. The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD
This distinction matters for anyone evaluating progesterone’s cortisol effects. The calming, stress-dampening properties often attributed to progesterone may largely belong to allopregnanolone. That explains why the route of administration makes a difference: oral progesterone passes through the liver and generates more allopregnanolone, while injected or infused progesterone largely skips that conversion step. It also explains why topical progesterone creams, which are popular in wellness circles, might not produce the same central nervous system effects since skin absorption and liver metabolism differ from oral dosing.
The clinical relevance of allopregnanolone extends beyond cortisol. Brexanolone, an FDA-approved treatment for postpartum depression, is a synthetic form of allopregnanolone. Its therapeutic effects are thought to involve restoring sensitivity in the brain’s stress-regulation circuits that may become dysregulated when progesterone and its metabolites plummet after delivery. The drug’s development reflects growing recognition that allopregnanolone’s calming influence on the brain’s stress axis is real and clinically meaningful, even if the parent hormone progesterone doesn’t directly suppress cortisol in every context.
Progesterone’s Weak Grip on the Glucocorticoid Receptor
One reason people believe progesterone lowers cortisol is the idea that it competes with cortisol for the same receptor, acting as a kind of blocker. There’s a kernel of truth here, but the reality is underwhelming. Progesterone does bind to glucocorticoid receptors, but with an affinity that ranges from about 16% to 41% of the binding strength of the natural glucocorticoid corticosterone, depending on the species and tissue tested.7PubMed. Species-related differences in steroid-binding specificity of glucocorticoid receptors in lung Other research looking specifically at rabbit thymic tissue found that progesterone’s binding to the glucocorticoid receptor was weak.8American Journal of Obstetrics and Gynecology. Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate (17-OHPC), and related progestins
In practice, this means progesterone can occupy glucocorticoid receptors in a test tube but probably doesn’t compete strongly enough at normal physiological concentrations to meaningfully block cortisol’s action in most tissues. Pregnancy is the exception people point to, since progesterone levels climb to extraordinary heights, but even the high-dose infusion study in men mimicking pregnancy concentrations found no antiglucocorticoid effect. The receptor-competition theory, while biochemically plausible on paper, hasn’t held up well in human studies.
Enzyme-Level Effects on Cortisol Metabolism
Beyond receptor competition, progesterone influences the enzymes that activate or deactivate cortisol in specific tissues. This is where the biology gets genuinely interesting and also more confusing.
In bovine ovarian cells, progestogens decreased cortisol production by suppressing the enzyme HSD11B1, which converts inactive cortisone into active cortisol.9PubMed Central. Progesterone modulates HSD11B1-mediated cortisol production in luteinized bovine granulosa cells Less HSD11B1 activity means less local cortisol production in those cells, which could matter for ovarian function and fertility. But this finding is tissue-specific and comes from cow cells, so extrapolating it to whole-body cortisol levels in humans is a stretch.
Meanwhile, in human placental tissue, progesterone inhibited a different enzyme: 11β-HSD2, which does the opposite job, converting active cortisol into inactive cortisone.10Biology of Reproduction. Regulation of 11β-Hydroxysteroid Dehydrogenase Type 2 by Progesterone, Estrogen, and the Cyclic Adenosine 5′-Monophosphate Pathway in Cultured Human Placental and Chorionic Trophoblasts By blocking the enzyme that deactivates cortisol, progesterone could actually increase local cortisol exposure in placental tissue. This likely serves a purpose during pregnancy, since the developing fetus needs some cortisol for organ maturation, but it’s the opposite of “lowering cortisol.”
The takeaway from the enzyme research is that progesterone’s effects on cortisol metabolism are tissue-specific and sometimes contradictory. In one tissue it may reduce cortisol production; in another it may prevent cortisol from being cleared. Whole-body claims about progesterone lowering cortisol gloss over this complexity.
Oral Contraceptives and Cortisol
Oral contraceptive pills contain synthetic progestins alongside synthetic estrogens, so you might expect them to lower cortisol if progestins behaved like natural progesterone. They don’t. Women taking combined oral contraceptives consistently show higher total cortisol, higher free cortisol, and higher levels of cortisol’s transport protein (corticosteroid-binding globulin) compared to women not on the pill.11PubMed Central. Differential Effects of Estrogen on Corticosteroid-Binding Globulin Forms Suggests Reduced Cleavage in Pregnancy 12Clinica Chimica Acta. The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone
The rise in total cortisol is largely driven by estrogen’s effect on the liver, which ramps up production of cortisol-binding globulin. But it’s worth noting that even free cortisol, the fraction that’s biologically active, was elevated in pill users in these studies. The synthetic progestin component did not offset or reverse this effect. One exercise study found that women on oral contraceptives failed to show the exercise-induced cortisol rise seen in naturally cycling controls, which might suggest a blunted stress response, but the baseline cortisol levels in those women were already elevated.13PubMed Central. Substrate and hormonal responses to exercise in women using oral contraceptives
Synthetic progestins differ substantially from natural (bioidentical) progesterone in their receptor activity, metabolism, and downstream effects. Levonorgestrel, norethindrone, and drospirenone each have different pharmacological profiles. Drospirenone, for instance, has antimineralocorticoid properties that natural progesterone also shares, but it doesn’t generate meaningful amounts of allopregnanolone the way oral micronized progesterone does. So the oral contraceptive data shouldn’t be taken as evidence that natural progesterone raises cortisol, but it does caution against assuming that any progestational compound will lower it.
Hormone Replacement Therapy in Menopause
Postmenopausal hormone therapy provides another lens, though the results are frustratingly inconsistent. In one study, estrogen-only therapy significantly increased cortisol, while adding progesterone to estrogen showed only a trend toward higher cortisol without reaching statistical significance.14PubMed Central. Effects of estrogen versus estrogen and progesterone on cortisol and interleukin-6 That could be interpreted as progesterone partially offsetting estrogen’s cortisol-raising effect, but the difference wasn’t clear-cut.
A different study found that cortisol decreased significantly after six months of transdermal estradiol and after twelve months of conjugated estrogen plus medroxyprogesterone acetate (a synthetic progestin).15PubMed. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels Yet another study measuring 24-hour cortisol profiles found no difference at all between postmenopausal women on estrogen-progestin therapy and those on placebo.16The Journal of Clinical Endocrinology & Metabolism. 24-Hour Serum Levels of Growth Hormone, Prolactin, and Cortisol in Pre- and Postmenopausal Women: The Effect of Combined Estrogen and Progestin Treatment
The inconsistency likely reflects differences in the type of progestin used (bioidentical progesterone versus synthetic progestins), the route of estrogen delivery (oral versus transdermal, which affects liver metabolism differently), the duration of treatment, and when cortisol was measured. If you’re on or considering hormone replacement therapy, the evidence doesn’t support expecting a clear drop in cortisol as a side benefit of progesterone inclusion.
The Circadian Puzzle
One detail that often goes unmentioned in popular articles: during the follicular phase, when progesterone is low, progesterone and cortisol levels actually track together positively across the day. The same positive correlation between the two hormones’ daily profiles was observed in postmenopausal women.17Taylor & Francis Online (Chronobiology International). Circadian profiles of progesterone, gonadotropins, cortisol and corticotropin in cycling and postmenopausal women During pregnancy, both progesterone and cortisol follow circadian rhythms, but intriguingly, they cycle in reverse phase, with progesterone peaking when cortisol dips.18PubMed. The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy
These patterns don’t fit a simple story. If progesterone directly suppressed cortisol, you’d expect them to always move in opposite directions. Instead, their relationship appears context-dependent, running in parallel under some conditions and in opposition under others. The pregnancy finding of reversed circadian phasing is interesting, but pregnancy involves such extreme hormonal changes across so many axes that isolating progesterone’s individual contribution is nearly impossible.
Premenstrual Dysphoric Disorder and Cortisol
Women with premenstrual dysphoric disorder (PMDD) offer a clinically relevant case study. Research has found that women with PMDD who had higher progesterone levels during the luteal phase also tended to experience greater symptom severity. These same women showed higher cortisol levels in the late luteal phase compared to healthy controls.19PubMed. Estrogen, progesterone, cortisol, brain-derived neurotrophic factor, and vascular endothelial growth factor during the luteal phase of the menstrual cycle in women with premenstrual dysphoric disorder
This doesn’t mean progesterone caused the cortisol elevation, but it does challenge a simplistic model. In a group of women particularly sensitive to hormonal fluctuations, higher progesterone and higher cortisol appeared together during the same cycle phase. PMDD is increasingly understood as a condition involving abnormal sensitivity to normal hormonal changes rather than abnormal hormone levels per se, so the finding may reflect a dysregulated stress axis responding atypically to progesterone or its metabolites.
What Actually Works If You Want to Lower Cortisol
Given all this complexity, taking progesterone specifically to reduce cortisol is not well supported by the evidence. The effects are small, inconsistent, route-dependent, and sometimes operate in the opposite direction from what you’d expect. If you’re concerned about elevated cortisol, the interventions with far more consistent evidence include regular moderate exercise, adequate sleep, stress-management practices like mindfulness, and addressing any underlying medical condition that might be driving excess cortisol production.
If a healthcare provider has prescribed progesterone for a legitimate indication, such as menopausal symptom management, luteal phase support, or endometrial protection during estrogen therapy, any calming or stress-buffering effects you notice may be real. They’re likely mediated by allopregnanolone rather than by a direct cortisol-lowering mechanism. But seeking out progesterone primarily as a cortisol-management tool, especially through over-the-counter creams or supplements that may not even deliver reliable blood levels, rests on a foundation the research hasn’t solidified. The biology connecting progesterone and cortisol is real, fascinating, and the subject of ongoing investigation, but it operates through multiple pathways pulling in different directions rather than through a single clean suppressive effect.